Clinical Trial Update: Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating combined aspirin and IVIG-SN therapy for Kawasaki disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Drugs mentioned

• Aspirin (Aspirin)
• IVIG-SN

Snippet

Sponsor: Green Cross Corporation | Conditions: Kawasaki Disease | Phase 4 | Status: COMPLETED